AbCellera Biologics Inc. (ABCL)

ABCL trades at $4.74, 18.5% above the near-term max pain of $4 expiring Oct 17, 2025 (19 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($3-$4), indicating stable market expectations. Key magnetic zone at 4 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ABCL shows stable levels around 3.67, reflecting balanced market expectations. The 27% spread signals divergent expectations across timeframes. Most levels below 4.74 may cap rallies. Strong magnetic level at 4 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.